The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.40
Bid: 178.60
Ask: 179.00
Change: -0.40 (-0.22%)
Spread: 0.40 (0.224%)
Open: 175.60
High: 180.40
Low: 175.60
Prev. Close: 179.80
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of 3C! Packaging, Inc.

17 Sep 2020 16:36

RNS Number : 3522Z
Essentra plc
17 September 2020
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014

 

17 September 2020

 

Essentra PLC

 

Acquisition of 3C! Packaging, Inc.

 

Introduction

Essentra PLC ("Essentra" or the "Company"), a leading global provider of essential components and solutions, today announces that it has signed a sale and purchase agreement (the "SPA") to purchase the entire issued share capital of 3C! Packaging, Inc. ("3C!") from each of Joseph Elphick, the Joseph Gerard Elphick Revocable Trust U/A/D November 5, 2010 and the Joseph G Elphick Legal Trust U/A/D December 21, 2021 (the "Acquisition") on a cash free, debt free basis, for total consideration of $65 million (approximately £50 million1) (the "Consideration"), with completion today. The Consideration has been paid in cash.

3C!, headquartered in North Carolina, USA, is a leading designer and manufacturer of custom folding cartons, printed literature, foil and flexible packaging and labels focused on the pharmaceuticals and healthcare sectors. On completion of the Acquisition, 3C! will join Essentra's Packaging division.

The Acquisition meets Essentra's strategic and financial criteria, by creating significant value, strengthening the Company's customer proposition and offering significant synergies.

Highlights of the Acquisition include:

- 3C! is a strategically located and industry leading packaging business, allowing Essentra to enhance its position in the pharmaceutical packaging space;

- the Acquisition is expected to further strengthen Essentra's industry leading packaging business, adding long-standing relationships with key blue-chip customers in the US pharmaceutical sector;

- creation of a North Carolina hub with three sites positioned in the number one pharmaceutical manufacturing area of the USA;

- 3C!'s leading, proprietary serialisation technology will supplement the Company's added value services;

- the 3C! leadership team will join the Company, providing significant experience in speciality packaging and serving the US pharmaceutical market;

- the Consideration represents a 5.7x multiple of pro-forma 3C! adjusted EBITDA of $7.3m (year to 30 June 2020) plus anticipated c.$4m synergies2,3,4;

- Acquisition meets internal ROIC benchmark by year 3; and

- revenue and margin synergies are expected from combining the Company's and 3C!'s customer base, optimised carton competitiveness and procurement synergies.

Paul Forman, Chief Executive Officer of Essentra, commented:

"3C! is a strong fit for Essentra with excellent growth prospects. The business further strengthens our position in pharmaceutical and healthcare packaging in core product areas we know well, in addition to bringing valuable new innovation to Essentra with its serialisation technology. The acquisition of 3C! follows the successful integration of Nekicesa which has performed strongly in the first year of Essentra ownership. With 3C! we will continue to build the Packaging division's track record for identifying, acquiring and integrating high quality businesses that meet our disciplined criteria and deliver sustainable value to Essentra over the long-term."

3C! overview

3C! is a leading designer and manufacturer of custom folding cartons, printed literature, foil and flexible packaging and labels, with 91%2 of revenue in the year to 30 June 2020 generated from pharmaceutical and healthcare customers.

Founded in 1979, 3C! is a privately held, family owned business headquartered in North Carolina, USA. The business is strategically located close to some of the biggest pharmaceutical clients in the US and has long-standing relationships with key blue-chip customers.

3C! is led by a highly experienced management team with significant experience in speciality packaging and serving the pharmaceutical market. It has a workforce of 280 multiskilled, cross-trained employees.

3C! has a strong financial track record of revenue and margin growth. Between 2016 and 2020, 3C!'s revenue grew at a compound annual growth rate ("CAGR") of 11.5%2. In the year to 30 June 2020, 3C! delivered revenue of $48.8 million2 at an adjusted EBITDA margin of 14.9%2,4. In the year to 30 June 2020, revenue was split approximately: 60%2 (folding cartons), 29%2 (printed literature) and 11%2 (flexible packaging and labels). 3C! has a state-of-the-art design centre and offers additional value add services, including its proprietary serialisation technology.

3C! is well-positioned for further development, given the compelling end-market dynamics of the packaging industry and 3C!'s organic growth initiatives. The Company anticipates additional revenue opportunities for 3C! through additional cross selling product opportunities with its existing strong, blue-chip customer base, new blue-chip customers onboarding and new product offerings and initiatives. There is also significant margin improvement and opportunities through lean manufacturing initiatives, increasing efficiency and reducing costs. The Company expects c.$4m in annual recurring synergies by year 3 delivered primarily through cost synergies, largely through network optimisation and procurement, continuous improvement and applying Essentra supplier arrangements and expertise. The cost to achieve these synergies of $3.2m is spread over the next 2 years. Further, the acquisition significantly accelerates the ability to recognize $4.3m (after tax) of deferred tax assets.

As at 30 June 2020, 3C! had gross assets of $18.9 million2 and Profit before Tax of $3.0 million2 in the year to 30 June 2020.

The Acquisition constitutes a Class 2 transaction for the purposes of the FCA's Listing Rules.

The person responsible for releasing this announcement is Jon Green (General Counsel & Company Secretary).

1 Based on GBP:USD exchange rate of 1.30 as of 16 September 2020

2 Based on reviewed, unaudited financial information

3 Full year synergies expected to be achieved by year 3

4 Adjustments made to 3C! Packaging management's adjusted EBITDA of c.$7.9m total c.$0.6m of downward adjustments and comprise adjustments for COVID-19 related payroll tax credits, reversing an inventory reserve, normalising travel expenses post COVID-19, a customer rebate and normalised bonus adjustments.

 

For further information please contact:

Essentra PLC

Paul Forman, Chief Executive

Lily Liu, Chief Financial Officer

Aamir Mohiuddin, Investor Relations Director

Lucy Yank, Group Communications Director

 

via Tulchan

Tulchan Communications LLP (Financial PR)

Martin Robinson / Sophia Martin-Pavlou / Olivia Peters

+44 (0)20 7353 4200

 

IMPORTANT NOTICES

This Announcement is not for public release, publication, distribution or forwarding, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction in which such release, publication, distribution or forwarding would be unlawful.

All information regarding 3C! is based on information provided by the management of 3C! and has not been independently verified and accordingly, each of the Company, Jefferies, Peel Hunt, their respective affiliates and their respective Representatives expressly disclaim, to the maximum extent permitted by law, any responsibility or liability arising in connection with the information in this Announcement relating to 3C! Unless otherwise indicated, historical financial information relating to 3C! has been extracted without adjustment from 3C!'s financial statements. Such financial statements have not been audited but reviewed, the objective of which is not to express an opinion regarding the financial statements as a whole. A review is substantially less in scope than an audit and in this case was limited to the application of analytical procedures to management's financial data and making inquiries of 3C!'s management. The information in this Announcement is subject to change.

Certain statements in this Announcement are forward-looking statements with respect to the Company's expectations, intentions and projections regarding its future performance, strategic initiatives, anticipated events or trends and other matters that are not historical facts and which are, by their nature, inherently predictive, speculative and involve risks and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. All statements that address expectations or projections about the future, including statements about operating performance, strategic initiatives, objectives, market position, industry trends, general economic conditions, expected expenditures, expected cost savings and financial results are forwardlooking statements. Any statements contained in this Announcement that are not statements of historical fact are, or may be deemed to be, forwardlooking statements. These forward-looking statements, which may use words such as "aim", "anticipate", "believe", "could", "intend", "estimate", "expect", "may", "plan", "project" or words or terms of similar meaning or the negative thereof, are not guarantees of future performance and are subject to known and unknown risks and uncertainties. There are a number of factors including, but not limited to, commercial, operational, economic and financial factors, that could cause actual results, financial condition, performance or achievements to differ materially from those expressed or implied by these forwardlooking statements. Many of these risks and uncertainties relate to factors that are beyond the Company's ability to control or estimate precisely, such as changes in taxation or fiscal policy, future market conditions, currency fluctuations, the behaviour of other market participants, the actions of governments or governmental regulators, or other risk factors, such as changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including inflation, recession and consumer confidence, on a global, regional or national basis. Given those risks and uncertainties, readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of this Announcement. Each of the Company, Jefferies and Peel Hunt expressly disclaims any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise unless required to do so by applicable law or regulation.

No statement in this Announcement is intended to be a profit forecast or profit estimate for any period and no statement in this Announcement should be interpreted to mean that earnings, earnings per share or income, cash flow from operations or free cash flow for the Company for the current or future financial periods would necessarily match or exceed the historical published earnings, earnings per share or income, cash flow from operations or free cash flow for the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBUGDCBXBDGGR
Date   Source Headline
21st Apr 20205:00 pmRNSHolding(s) in Company
14th Apr 20207:00 amRNS2019 Annual Report & 2020 Notice of AGM
2nd Apr 20203:30 pmRNSJoint Venture
1st Apr 202011:07 amRNSTotal Voting Rights
27th Mar 20207:00 amRNSCOVID-19 Update
20th Mar 202010:21 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
17th Mar 20203:03 pmRNSHolding(s) in Company
6th Mar 20203:22 pmRNSTotal Voting Rights - Replacement
2nd Mar 202012:02 pmRNSTotal Voting Rights
28th Feb 20207:00 amRNSFinal Results
24th Feb 20203:58 pmRNSHolding(s) in Company
12th Feb 20202:00 pmRNSNotice of Results
3rd Feb 202010:40 amRNSTotal Voting Rights
2nd Jan 20209:23 amRNSTotal Voting Rights
6th Dec 20193:00 pmRNSJoint Venture
2nd Dec 20194:37 pmRNSTotal Voting Rights
27th Nov 20197:00 amRNSJoint Venture
1st Nov 20195:10 pmRNSDirector/PDMR Shareholding
1st Nov 20195:01 pmRNSTotal Voting Rights
25th Oct 20197:00 amRNS3rd Quarter Results
23rd Oct 201910:37 amRNSHolding(s) in Company
23rd Oct 201910:35 amRNSHolding(s) in Company
1st Oct 20198:21 amRNSTotal Voting Rights
9th Sep 20197:00 amRNSAcquisition of Nekicesa Packaging S.L.
3rd Sep 20193:45 pmRNSTotal Voting Rights
15th Aug 20198:28 amRNSDirector/PDMR Shareholding
15th Aug 20198:26 amRNSDirector/PDMR Shareholding
14th Aug 201911:08 amRNSDirector/PDMR Shareholding
5th Aug 20197:35 amRNSTotal Voting Rights
2nd Aug 20197:00 amRNSResults for the Half Year Ended 30 June 2019
19th Jul 201910:56 amRNSInvitation to Half Year 2019 Results Presentation
1st Jul 20199:45 amRNSTotal Voting Rights
1st Jul 20197:00 amRNSCompletion of Divestment of Speciality Tapes
27th Jun 20197:00 amRNSAcquisition of Innovative Components
20th Jun 20197:00 amRNSDivestment of Speciality Tapes business
11th Jun 20197:00 amRNSDivestment of Extrusion business
6th Jun 201911:54 amRNSDirector/PDMR Shareholding
3rd Jun 201912:22 pmRNSTotal Voting Rights
3rd Jun 201912:21 pmRNSDirector Declaration
24th May 20197:02 amRNS2019 AGM Results
23rd May 20197:00 amRNSAnnual General Meeting - Trading Update
8th May 20192:12 pmRNSDirector/PDMR Shareholding
7th May 201910:53 amRNSDirector/PDMR Shareholding
1st May 20194:20 pmRNSTotal Voting Rights
12th Apr 20191:40 pmRNSDirector/PDMR Shareholding
12th Apr 201912:20 pmRNSDirector/PDMR Shareholding
8th Apr 20199:54 amRNS2019 Annual General Meeting and Trading Update
3rd Apr 20198:25 amRNSAnnual Report 2018 & 2019 AGM Notice
2nd Apr 20199:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.